Manufacturer:
Novartis
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Enrollment Forms:
Synergen Prescription Form
Approved Indication:
- treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older
- treatment of chronic iron overload in patients 10 years of age and older with non-transfusion-dependent thalassemia syndromes and with a liver iron (Fe) concentration of at least 5mg Fe per gram of dry weight and a serum ferritin greater than 300mcg/L
Conditions:
- Sickle Celll Disease
- Anemia
- Non-Transfusion-Dependent Thalassemia
Therapeutic Area:
- Oncology